ArticleScientific reports2023

KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3β-β-catenin pathway.

Junmei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.